FDA
-
-
-
-
-
-
-
Tandem Diabetes Care Issues Voluntary Medical Device Correction for Select t:slim X2 Insulin Pumps
-
-
-
-
-
-
-
Morgan Stanley Upgrades Tandem Diabetes Care (TNDM) to Overweight
-
-
-
-
-
-
-
TANDEM DIABETES CARE, INC. SHAREHOLDER ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
-
-
-
-
-
-
-
Tandem Diabetes (TNDM) to acquire insulin patch pump developer AMF Medical
-
-
-
-
-
-
-
Tandem Diabetes Care Announces First Quarter 2022 Financial Results and Updated Full Year 2022 Financial Guidance
-
-
-
-
-
-
-
Abbott (ABT), Tandem Diabetes Care (TNDM) Advance Development of Integrated Technologies for Future Automated Insulin Delivery Systems
-
-
-
-
-
-
-
Tandem Diabetes Care Announces FDA Designation of Basal-IQ Technology as an Interoperable Automated Glycemic Controller
-
323,573 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

